DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 10, 2018

Primary Completion Date

March 8, 2021

Study Completion Date

March 8, 2021

Conditions
Coronary Artery Disease
Interventions
DEVICE

DynamX Sirolimus-eluting Coronary Bioadaptor System

de novo native coronary artery lesions

Trial Locations (7)

1023

Auckland City Hospital, Auckland

6023

Wellington Hospital, Wellington

0622

North Shore Hospital, Auckland

Unknown

Middlemore Hospital, Auckland

Christchurch Hospital, Christchurch

Dunedin Hospital, Dunedin

Waikato Hospital, Hamilton

Sponsors
All Listed Sponsors
lead

Elixir Medical Corporation

INDUSTRY

NCT03634020 - DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System | Biotech Hunter | Biotech Hunter